logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Asahi Kasei Corporation Announces Public Tender Offer to Acquire Calliditas Therapeutics AB (publ)

May 28, 2024•over 1 year ago

Acquiring Company

Asahi Kasei Corporation

Acquired Company

Calliditas

TokyoStockholmHealth CarePharmaceutical Manufacturing

Description

Asahi Kasei Corporation has announced a public tender offer to acquire Calliditas Therapeutics AB (publ), a Swedish biopharmaceutical company specializing in innovative treatments for kidney diseases. The offer involves a cash purchase of shares and American Depositary Shares (ADS) with the aim of expanding Asahi Kasei's presence in the healthcare sector.

Company Information

Company

Asahi Kasei Corporation

Location

Tokyo, Tokyo, Japan

About

The Asahi Kasei Group contributes to life and living for people around the world. Since its foundation in 1922 with ammonia and cellulose fiber business, Asahi Kasei has consistently grown through the proactive transformation of its business portfolio to meet the evolving needs of every age. With more than 48,000 employees around the world, the company contributes to sustainable society by providing solutions to the world’s challenges through its three business sectors of Material, Homes, and Health Care.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed